Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  

Cardiovascular Pharmacology: Open Access

Open Access
ISSN: 2329-6607
In Association with

Upcoming Event


Upcoming Special Issues

Special issue entitled: " Hypertension and Aging" has been edited by

Mingyi Wang
Division of Cardiology
Johns Hopkins School of Bloomberg Public Health
Tel: 410-558-8112

Special issue entitled: "Management of Hypertension" has been edited by

Wilbert S Aronow
Department of Medicine
New York Medical College
Office (914) 493-5311

Read More»

About the Journal

Here you can find about Cardiovascular Pharmacology: Open Access, their increasing role in the diagnosis, characterization, therapy of various marked diseases and in other crucial fields of Medical Science. To promote international dialogue and collaboration on health issues; to improve clinical practice; and to expand and deepen the understanding of health and health care.
The journal includes a wide range of fields in its discipline to create a platform for the authors to make their contribution towards the journal and the editorial office promises a peer review process for the submitted manuscripts for the quality of publishing
Cardiovascular Pharmacology: Open Access is an Open Access journal and aims to publish most complete and reliable source of information on the discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in all areas of the field and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
flyer image
Cardiovascular Pharmacology Journal is at higher echelons that enhance the intelligence and information dissemination on topics closely related to Cardiovascular Pharmacology. The Journal provides a unique forum dedicated to scientists to express their research articles, review articles, case reports and short communications on an array of Cardiovascular Pharmacology research. The Cardiovascular Pharmacology Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Cardiovascular Pharmacology journal impact factor is mainly calculated based on the number of articles that undergo a double blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles. Abstracts and full texts of all articles published by Cardiovascular Pharmacology Open Access Journal is freely accessible to everyone immediately after publication.
OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies, 400+ symposiums and Publishes 500+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
The 5th International Conference on Clinical & Experimental Cardiology to be held at Philadelphia, USA during April 27-29, 2015 organized by OMICS Group Conferences will bring together world-class professors, scientists and cardiologists to discuss strategies for disease remediation for heart. Cardiology International conference is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease. The conference will be organized around the theme "Blooming landscapes in cardio research. Cardiology-2015 is comprised of 8 tracks designed to offer comprehensive sessions that address current issues in Cardiology.
 Submit manuscript at www.editorialmanager.com/pharma/or send as an e-mail attachment to the Editorial Office at editor.cpo@omicsonline.org
  Aims and Scope



Recently published articles

Profound Shock after Initiation of Clozapine Therapy

Andrew Choi, Payal Sud and Howard Greller

Telmisartan is More Effective than Taurine in Protecting High Fat Diet Induced Obesity in Rats from Hypertension, Some Metabolic, Oxidative Stress and Vascular Complications

Maha Mohamed El Batsh and Manal Mohamed El Batch

Transhepatic Approach for Device Closure of Secundum Atrial Septal Defect in Patient with Interrupted Inferior Vena Cava

Nadeem Sadiq

Donepezil, Therapeutic Acetylcholinesterase Inhibitor, Prevents the Progression of Ventricular Dysfunction by Promoting Myocardial Glucose Utilization in Rat Model of Chronic Heart Failure Following Myocardial Infarction

Mikihiko Arikawa, Yoshihiko Kakinuma, Tatsuya Noguchi and Takayuki Sato

Congestive Cardiac Failure in Children: An Update on Patho-physiology and Management

Rashmi Ranjan Das, Shasanka Shekhar Panda, Meely Panda and Sushree Samiksha Naik

Systolic Blood Pressure Levels Associated with Cardiovascular Events and All-cause Mortality: Results from the REGARDS Study

Aronow WS

Drugs for the Prevention and Treatment of Cardiac Allograft Vasculopathy

Shuchita Gupta MD

Meet us at our 300+ Global Events in Pharma, Medicine, Science and Technology

Our 2015 Major destinations:
Conferences By Country
   USA    Spain
   Australia   Canada
   UAE   China
   Italy   France
   Germany   India
   UK   Malaysia
   Japan   Singapore
   Brazil   South Africa
  South Korea
Conferences By City
Chicago Valencia Beijing
Florida Alicante Houston
Philadelphia Rome San Antonio
Baltimore Birmingham Abu Dhabi
Boston Lexington Las Vegas
Seattle Atlanta Barcelona
New Orleans Brisbane San Francisco
Bengaluru New Delhi Toronto
Dubai London Hyderabad
Conferences By Subject
Medical Pharma Veterinary
Agri, Food & Aqua Genetics Molecular Biology
Physics Health care Neuroscience
Chemistry Immunology Nursing
Clinical Massmedia Physics
Environmental Materials Science Microbiology
EEE Environmental  
Chemical Engineering Business & Management
© 2008-2014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version